JUNS ▲ +0.4% - Jupiter Neurosciences, Inc. $JUNS - Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value 06-OCT-2026 11:15 AM ET